Nash, Richard A <br/><br/>
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report.  [electronic resource] 

 -  JAMA neurology  Feb 2015 
 - 159-69 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>2168-6157 
<br/><br/><label>Standard No.: </label>10.1001/jamaneurol.2014.3780  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Combined Modality Therapy<br/>Disease Progression<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--diagnosis<br/>Transplantation, Autologous--adverse effects<br/>Treatment Outcome